Ming-Shian Kao

1.7k total citations
36 papers, 1.3k citations indexed

About

Ming-Shian Kao is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Ming-Shian Kao has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Obstetrics and Gynecology, 12 papers in Reproductive Medicine and 9 papers in Surgery. Recurrent topics in Ming-Shian Kao's work include Endometrial and Cervical Cancer Treatments (17 papers), Uterine Myomas and Treatments (9 papers) and Ovarian cancer diagnosis and treatment (8 papers). Ming-Shian Kao is often cited by papers focused on Endometrial and Cervical Cancer Treatments (17 papers), Uterine Myomas and Treatments (9 papers) and Ovarian cancer diagnosis and treatment (8 papers). Ming-Shian Kao collaborates with scholars based in United States, Israel and Ireland. Ming-Shian Kao's co-authors include H. Marvin Camel, Andrew E. Galakatos, Carlos A. Pérez, Perry W. Grigsby, Mary Ann Lockett, Carlos A. Perez, Michael T. Mazur, Anna-Luise A. Katzenstein, John Leslie Collins and Perry W. Grigsby and has published in prestigious journals such as Science, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

Ming-Shian Kao

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming-Shian Kao United States 19 869 535 483 323 157 36 1.3k
John A. Stryker United States 24 588 0.7× 245 0.5× 449 0.9× 337 1.0× 341 2.2× 54 1.4k
Soon‐Beom Kang South Korea 24 821 0.9× 616 1.2× 288 0.6× 373 1.2× 152 1.0× 62 1.5k
Dae‐Shik Suh South Korea 23 720 0.8× 710 1.3× 384 0.8× 156 0.5× 124 0.8× 78 1.4k
Mika Mizuno Japan 23 488 0.6× 612 1.1× 225 0.5× 161 0.5× 185 1.2× 77 1.2k
Jørn Andersen Denmark 20 209 0.2× 425 0.8× 267 0.6× 46 0.1× 107 0.7× 36 1.0k
Jamal Rahaman United States 18 522 0.6× 571 1.1× 252 0.5× 64 0.2× 83 0.5× 52 1.3k
Mark K. Dodson United States 15 309 0.4× 281 0.5× 180 0.4× 95 0.3× 80 0.5× 42 870
Susan Zweizig United States 15 397 0.5× 429 0.8× 190 0.4× 155 0.5× 118 0.8× 32 925
J Chauvergne France 16 166 0.2× 132 0.2× 219 0.5× 107 0.3× 208 1.3× 107 833
Alberto A. Mendivil United States 18 735 0.8× 521 1.0× 417 0.9× 83 0.3× 86 0.5× 45 1.4k

Countries citing papers authored by Ming-Shian Kao

Since Specialization
Citations

This map shows the geographic impact of Ming-Shian Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Shian Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Shian Kao more than expected).

Fields of papers citing papers by Ming-Shian Kao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-Shian Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Shian Kao. The network helps show where Ming-Shian Kao may publish in the future.

Co-authorship network of co-authors of Ming-Shian Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Ming-Shian Kao. A scholar is included among the top collaborators of Ming-Shian Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-Shian Kao. Ming-Shian Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Christopher, Ming-Shian Kao, & Deborah J. Gersell. (2008). Incidental placental choriocarcinoma in a term pregnancy: a case report. Journal of Medical Case Reports. 2(1). 330–330. 17 indexed citations
2.
Buekers, Thomas, et al.. (2006). The treatment of early stage cervical cancer: An assessment of pre-operative factors. Gynecologic Oncology. 104(3). 665–669. 1 indexed citations
3.
4.
Grigsby, Perry W., Mary V. Graham, Carlos A. Perez, et al.. (1996). Prospective Phase I/II Studies of Definitive Irradiation and Chemotherapy for Advanced Gynecologic Malignancies. American Journal of Clinical Oncology. 19(1). 1–6. 17 indexed citations
5.
Chao, C., Perry W. Grigsby, Carlos A. Perez, et al.. (1995). Brachytherapy-related complications for medically inoperable Stage I endometrial carcinoma. International Journal of Radiation Oncology*Biology*Physics. 31(1). 37–42. 30 indexed citations
6.
Kao, Ming-Shian, et al.. (1993). Interferon alfa activates a lytic mechanism in ovarian and cervical carcinoma cells. American Journal of Obstetrics and Gynecology. 169(3). 661–667. 2 indexed citations
7.
Perez, Carlos A., Perry W. Grigsby, H. Marvin Camel, et al.. (1992). Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 69(11). 2796–2806. 225 indexed citations
8.
Herzog, Thomas J., Peter Kim Nelson, David G. Mutch, et al.. (1992). Effects of radiation on TNFα-mediated cytolysis of cell lines derived from cervical carcinomas. Gynecologic Oncology. 47(2). 196–202. 4 indexed citations
9.
Grigsby, Perry W., Carlos A. Pérez, Joseph R. Simpson, et al.. (1992). Clinical stage i endometrial cancer: Prognostic factors for local control and distant metastasis and implications of the new figo surgical staging system. International Journal of Radiation Oncology*Biology*Physics. 22(5). 905–911. 97 indexed citations
10.
Pérez, Carlos A., Mary Ann Lockett, Perry W. Grigsby, et al.. (1991). Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods. International Journal of Radiation Oncology*Biology*Physics. 21(4). 885–898. 124 indexed citations
11.
Mutch, David G., L. Stewart Massad, Ming-Shian Kao, & John Leslie Collins. (1990). Proliferative and antiproliferative effects of interferon-'Y and tumor necrosis factor-α. on cell lines derived from cervical and ovarian malignancies. American Journal of Obstetrics and Gynecology. 163(6). 1920–1924. 23 indexed citations
12.
Mutch, David G., et al.. (1990). Common expression of a tumor necrosis factor resistance mechanism among gynecological malignancies. Cancer Immunology Immunotherapy. 32(2). 131–136. 14 indexed citations
13.
Powell, C. Bethan, et al.. (1989). In vitro analysis of the anticancer potential of tumor necrosis factor in combination with cisplatin. Gynecologic Oncology. 34(3). 328–333. 24 indexed citations
14.
Kao, Ming-Shian, et al.. (1989). The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells. Cancer Immunology Immunotherapy. 29(1). 17–22. 27 indexed citations
15.
Jacobs, Allan J., et al.. (1988). Therapy of ovarian carcinoma: The relationship of dose level and treatment intensity to survival. Gynecologic Oncology. 31(1). 233–245. 6 indexed citations
16.
Jacobs, Allan J., et al.. (1988). Serum copper in ovarian carcinoma. Cancer. 61(5). 1015–1017. 2 indexed citations
17.
Jacobs, Allan J., et al.. (1986). Carcinoma of the fallopian tube: Management and sites of failure. Cancer. 58(9). 2070–2075. 73 indexed citations
18.
Stokes, Steven, John M. Bedwinek, Carlos A. Pérez, H. Marvin Camel, & Ming-Shian Kao. (1986). Hysterectomy and adjuvant irradiation for pathologic stage III adenocarcinoma of the endometrium. International Journal of Radiation Oncology*Biology*Physics. 12(3). 335–338. 3 indexed citations
19.
Katzenstein, Anna-Luise A., et al.. (1979). Proliferative Serous Tumors of the Ovary. Histologic Features and Prognosis. Obstetrical & Gynecological Survey. 34(8). 619–620. 1 indexed citations
20.
Katzenstein, Anna-Luise A., et al.. (1978). Proliferative serous tumors of the ovary. The American Journal of Surgical Pathology. 2(4). 339–356. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Stryker Breakdown of academic impact, for papers by Soon‐Beom Kang Breakdown of academic impact, for papers by Dae‐Shik Suh Breakdown of academic impact, for papers by Mika Mizuno Breakdown of academic impact, for papers by Jørn Andersen Breakdown of academic impact, for papers by Jamal Rahaman Breakdown of academic impact, for papers by Mark K. Dodson Breakdown of academic impact, for papers by Susan Zweizig Breakdown of academic impact, for papers by J Chauvergne Breakdown of academic impact, for papers by Alberto A. Mendivil
Rankless by CCL
2026